Sun Pharmaceutical Industries Ltd announced today that one of its wholly-owned subsidiaries has entered into a licence agreement with Ferring Pharmaceuticals Private Limited, a subsidiary of Switzerland-based biopharmaceuticals MNC Ferring Pharmaceuticals, to commercialise a room temperature stable (RTS) formulation of the obstetric drug, CARITEC (Carbetocin RTS) in India.